Logo image of CYH

COMMUNITY HEALTH SYSTEMS INC (CYH) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CYH - US2036681086 - Common Stock

3.57 USD
-0.06 (-1.65%)
Last: 12/5/2025, 8:12:29 PM
3.57 USD
0 (0%)
After Hours: 12/5/2025, 8:12:29 PM
Fundamental Rating

4

Overall CYH gets a fundamental rating of 4 out of 10. We evaluated CYH against 100 industry peers in the Health Care Providers & Services industry. While CYH is still in line with the averages on profitability rating, there are concerns on its financial health. CYH has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CYH was profitable.
CYH had a positive operating cash flow in the past year.
In multiple years CYH reported negative net income over the last 5 years.
CYH had a positive operating cash flow in 4 of the past 5 years.
CYH Yearly Net Income VS EBIT VS OCF VS FCFCYH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B

1.2 Ratios

The Return On Assets of CYH (2.49%) is comparable to the rest of the industry.
CYH has a better Return On Invested Capital (7.73%) than 73.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CYH is below the industry average of 9.42%.
The 3 year average ROIC (5.27%) for CYH is below the current ROIC(7.73%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.49%
ROE N/A
ROIC 7.73%
ROA(3y)-1.43%
ROA(5y)0.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.27%
ROIC(5y)5.43%
CYH Yearly ROA, ROE, ROICCYH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 300

1.3 Margins

The Profit Margin of CYH (2.60%) is better than 64.00% of its industry peers.
With a decent Operating Margin value of 8.56%, CYH is doing good in the industry, outperforming 76.00% of the companies in the same industry.
CYH's Operating Margin has been stable in the last couple of years.
With an excellent Gross Margin value of 84.78%, CYH belongs to the best of the industry, outperforming 97.00% of the companies in the same industry.
CYH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.56%
PM (TTM) 2.6%
GM 84.78%
OM growth 3Y-13.59%
OM growth 5Y-0.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.44%
GM growth 5Y0.21%
CYH Yearly Profit, Operating, Gross MarginsCYH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CYH is creating some value.
The number of shares outstanding for CYH has been increased compared to 1 year ago.
The number of shares outstanding for CYH has been increased compared to 5 years ago.
CYH has a worse debt/assets ratio than last year.
CYH Yearly Shares OutstandingCYH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CYH Yearly Total Debt VS Total AssetsCYH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

Based on the Altman-Z score of 0.95, we must say that CYH is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CYH (0.95) is worse than 74.00% of its industry peers.
CYH has a debt to FCF ratio of 74.16. This is a negative value and a sign of low solvency as CYH would need 74.16 years to pay back of all of its debts.
The Debt to FCF ratio of CYH (74.16) is worse than 62.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 74.16
Altman-Z 0.95
ROIC/WACC1.39
WACC5.54%
CYH Yearly LT Debt VS Equity VS FCFCYH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

CYH has a Current Ratio of 1.47. This is a normal value and indicates that CYH is financially healthy and should not expect problems in meeting its short term obligations.
CYH has a Current ratio of 1.47. This is comparable to the rest of the industry: CYH outperforms 56.00% of its industry peers.
CYH has a Quick Ratio of 1.32. This is a normal value and indicates that CYH is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.32, CYH is in line with its industry, outperforming 52.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 1.32
CYH Yearly Current Assets VS Current LiabilitesCYH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

4

3. Growth

3.1 Past

CYH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 175.49%, which is quite impressive.
CYH shows a small growth in Revenue. In the last year, the Revenue has grown by 0.73%.
CYH shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.89% yearly.
EPS 1Y (TTM)175.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%523.33%
Revenue 1Y (TTM)0.73%
Revenue growth 3Y0.71%
Revenue growth 5Y-0.89%
Sales Q2Q%-0.1%

3.2 Future

CYH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.62% yearly.
The Revenue is expected to grow by 1.92% on average over the next years.
EPS Next Y160.8%
EPS Next 2Y31.3%
EPS Next 3Y27.62%
EPS Next 5YN/A
Revenue Next Year-0.04%
Revenue Next 2Y0.41%
Revenue Next 3Y1.92%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CYH Yearly Revenue VS EstimatesCYH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B
CYH Yearly EPS VS EstimatesCYH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 4.64, which indicates a rather cheap valuation of CYH.
Based on the Price/Earnings ratio, CYH is valued cheaply inside the industry as 98.00% of the companies are valued more expensively.
CYH's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.49.
The Forward Price/Earnings Ratio is negative for CYH. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 4.64
Fwd PE N/A
CYH Price Earnings VS Forward Price EarningsCYH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

82.00% of the companies in the same industry are more expensive than CYH, based on the Enterprise Value to EBITDA ratio.
CYH's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CYH is cheaper than 98.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.46
EV/EBITDA 7.18
CYH Per share dataCYH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CYH's earnings are expected to grow with 27.62% in the coming years.
PEG (NY)0.03
PEG (5Y)N/A
EPS Next 2Y31.3%
EPS Next 3Y27.62%

0

5. Dividend

5.1 Amount

CYH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

COMMUNITY HEALTH SYSTEMS INC

NYSE:CYH (12/5/2025, 8:12:29 PM)

After market: 3.57 0 (0%)

3.57

-0.06 (-1.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-23 2025-10-23/amc
Earnings (Next)02-16 2026-02-16/amc
Inst Owners81.3%
Inst Owner Change-6.39%
Ins Owners7.71%
Ins Owner Change0%
Market Cap494.52M
Revenue(TTM)12.64B
Net Income(TTM)329.00M
Analysts54.12
Price Target4.12 (15.41%)
Short Float %7.78%
Short Ratio4.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)331.56%
Min EPS beat(2)52.57%
Max EPS beat(2)610.55%
EPS beat(4)3
Avg EPS beat(4)29.43%
Min EPS beat(4)-607.99%
Max EPS beat(4)610.55%
EPS beat(8)4
Avg EPS beat(8)-97.67%
EPS beat(12)6
Avg EPS beat(12)-58.76%
EPS beat(16)8
Avg EPS beat(16)-452.11%
Revenue beat(2)2
Avg Revenue beat(2)2.37%
Min Revenue beat(2)2.02%
Max Revenue beat(2)2.72%
Revenue beat(4)4
Avg Revenue beat(4)2.1%
Min Revenue beat(4)0.99%
Max Revenue beat(4)2.72%
Revenue beat(8)6
Avg Revenue beat(8)1.09%
Revenue beat(12)7
Avg Revenue beat(12)0.69%
Revenue beat(16)8
Avg Revenue beat(16)-0.09%
PT rev (1m)0%
PT rev (3m)17.85%
EPS NQ rev (1m)-211.69%
EPS NQ rev (3m)-121.29%
EPS NY rev (1m)3442.86%
EPS NY rev (3m)261.46%
Revenue NQ rev (1m)-0.13%
Revenue NQ rev (3m)-0.94%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)0.52%
Valuation
Industry RankSector Rank
PE 4.64
Fwd PE N/A
P/S 0.04
P/FCF 3.46
P/OCF 1
P/B N/A
P/tB N/A
EV/EBITDA 7.18
EPS(TTM)0.77
EY21.57%
EPS(NY)-0.28
Fwd EYN/A
FCF(TTM)1.03
FCFY28.92%
OCF(TTM)3.56
OCFY99.69%
SpS91.28
BVpS-10.84
TBVpS-36.4
PEG (NY)0.03
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 2.49%
ROE N/A
ROCE 9.78%
ROIC 7.73%
ROICexc 7.81%
ROICexgc 11.55%
OM 8.56%
PM (TTM) 2.6%
GM 84.78%
FCFM 1.13%
ROA(3y)-1.43%
ROA(5y)0.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.27%
ROIC(5y)5.43%
ROICexc(3y)5.3%
ROICexc(5y)5.61%
ROICexgc(3y)7.93%
ROICexgc(5y)8.5%
ROCE(3y)6.68%
ROCE(5y)6.87%
ROICexgc growth 3Y-11.89%
ROICexgc growth 5Y0.9%
ROICexc growth 3Y-11.33%
ROICexc growth 5Y0.93%
OM growth 3Y-13.59%
OM growth 5Y-0.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.44%
GM growth 5Y0.21%
F-Score9
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 74.16
Debt/EBITDA 6.93
Cap/Depr 78.48%
Cap/Sales 2.77%
Interest Coverage 1.35
Cash Conversion 32.26%
Profit Quality 43.47%
Current Ratio 1.47
Quick Ratio 1.32
Altman-Z 0.95
F-Score9
WACC5.54%
ROIC/WACC1.39
Cap/Depr(3y)81.42%
Cap/Depr(5y)81.99%
Cap/Sales(3y)3.33%
Cap/Sales(5y)3.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)175.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%523.33%
EPS Next Y160.8%
EPS Next 2Y31.3%
EPS Next 3Y27.62%
EPS Next 5YN/A
Revenue 1Y (TTM)0.73%
Revenue growth 3Y0.71%
Revenue growth 5Y-0.89%
Sales Q2Q%-0.1%
Revenue Next Year-0.04%
Revenue Next 2Y0.41%
Revenue Next 3Y1.92%
Revenue Next 5YN/A
EBIT growth 1Y34.08%
EBIT growth 3Y-12.97%
EBIT growth 5Y-1.39%
EBIT Next Year56.2%
EBIT Next 3Y17.59%
EBIT Next 5YN/A
FCF growth 1Y139.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y282.17%
OCF growth 3YN/A
OCF growth 5Y4.51%

COMMUNITY HEALTH SYSTEMS INC / CYH FAQ

What is the fundamental rating for CYH stock?

ChartMill assigns a fundamental rating of 4 / 10 to CYH.


What is the valuation status of COMMUNITY HEALTH SYSTEMS INC (CYH) stock?

ChartMill assigns a valuation rating of 6 / 10 to COMMUNITY HEALTH SYSTEMS INC (CYH). This can be considered as Fairly Valued.


How profitable is COMMUNITY HEALTH SYSTEMS INC (CYH) stock?

COMMUNITY HEALTH SYSTEMS INC (CYH) has a profitability rating of 5 / 10.


What are the PE and PB ratios of COMMUNITY HEALTH SYSTEMS INC (CYH) stock?

The Price/Earnings (PE) ratio for COMMUNITY HEALTH SYSTEMS INC (CYH) is 4.64 and the Price/Book (PB) ratio is -0.33.


Can you provide the expected EPS growth for CYH stock?

The Earnings per Share (EPS) of COMMUNITY HEALTH SYSTEMS INC (CYH) is expected to grow by 160.8% in the next year.